AgPlus Electrochemical COVID-19 Diagnostic Assay

SARS-CoV-2或COVID-19目前正在全球蔓延。人们对这种病毒知之甚少，但我们正在迅速了解情况，很明显，我们需要有良好、准确的诊断来支持隔离和治疗。已知的是，该病毒的连续间隔为4天，1-3%的人口可能出现症状前，但仍在传播病毒。感染后2-14天出现症状，97%的人在11.5天内出现症状。这是在我们的卫生保健系统不堪重负之前制止疾病传播的一项全球性挑战。AgPlus用于检测对COVID-19病毒的特异性免疫反应的诊断试验将允许a)对有症状的人进行确证性检测（排除规则）；理解在某些情况下，症状可能是由细菌感染引起的b)监测检测呈阳性的患者的治疗效果，以确保他们有反应，以及何时可以安全解除隔离c)有可能成为支持药物/疫苗开发的伴随诊断d)进行测试以确认患者以前是否感染过COVID-19。

SARS-CoV-2 or COVID-19 is currently spreading throughout the world. Little is understood about the virus but we are learning fast and it is clear that we need to have good, accurate diagnosis to support quarantine and treatment.What is known is that the virus has a serial interval of 4 days and 1-3% of the population may be pre-symptomatic but still transmitting the virus. It takes 2-14 days to show symptoms after infection with the 97% of people developing symptoms within 11.5 days. This is a global challenge to halt the spread of the disease before our healthcare systems become overwhelmed.AgPlus' diagnostic assay for detecting specific immune responses to the COVID-19 virus will allow for a) confirmatory testing (rule in rule out) of those with symptoms, understanding that in some instances the symptoms may be due to bacterial infection b) monitoring treatment efficacy in those that have tested positive to ensure they are responding and when safe to release from isolation c) potential to be a companion diagnostic to support drug/ vaccine development d) test to confirm if patient has previously been infected with COVID-19\.